ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,223Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 229

$764K Total Retail Price of All Prescriptions

Rank: 19 out of 229

692 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 692 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 692 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 708 534 1 1
AMLODIPINE BESYLATE 628 503 2 5
LISINOPRIL 616 523 3 2
OMEPRAZOLE 482 352 4 4
SIMVASTATIN 422 349 5 3
HYDROCODONE-ACETAMINOPHEN 388 257 S3 6 7
OXYCODONE HCL 289 65 S2 7 37
HYDROCHLOROTHIAZIDE 283 236 8 9
METFORMIN HCL 249 192 9 6
LOVASTATIN 238 187 10 11
CITALOPRAM HBR 237 159 11 21
LOSARTAN POTASSIUM 208 182 12 12
FUROSEMIDE 205 155 13 8
METOPROLOL TARTRATE 194 161 14 13
CRESTOR 184 163 15 30
PROAIR HFA 177 97 16 38
GABAPENTIN 148 92 17 10
FLUTICASONE PROPIONATE 147 102 18 23
ALENDRONATE SODIUM 144 129 19 14
ZOLPIDEM TARTRATE 142 71 20 20
ATENOLOL 141 135 21 19
POTASSIUM CHLORIDE 140 77 22 18
IBUPROFEN 140 98 22 60
METOPROLOL SUCCINATE 134 68 24 16
TRAZODONE HCL 130 64 25 34
PANTOPRAZOLE SODIUM 130 121 25 33
TAMSULOSIN HCL 121 110 27 24
CLONIDINE HCL 120 96 28 69
SPIRIVA 119 89 29 76
RANITIDINE HCL 117 77 30 32
PRAVASTATIN SODIUM 113 102 31 25
GLIPIZIDE 109 71 32 36
DONEPEZIL HCL 104 100 33 29
ALLOPURINOL 102 90 34 27
TERAZOSIN HCL 99 86 35 74
ROPINIROLE HCL 96 63 36 96
PAROXETINE HCL 88 53 37 49
GLYBURIDE 88 73 R 37 57
TRIAMTERENE-HCTZ 87 82 39 51
WARFARIN SODIUM 84 69 40 17
LOSARTAN-HYDROCHLOROTHIAZIDE 84 64 40 65
BACLOFEN 82 40 42 107
DILTIAZEM ER 82 36 42 123
FLOVENT HFA 78 53 44 115
CYMBALTA 76 27 45 64
DOXYCYCLINE HYCLATE 76 48 45 102
TRAMADOL HCL 74 57 47 26
DIOVAN 74 62 47 42
NAPROXEN 73 62 49 94
NEXIUM 71 18 50 48
GEMFIBROZIL 71 32 50 62
PROMETHAZINE HCL 70 0 R 52 147
CLONIDINE 69 58 53 179
MELOXICAM 69 28 53 45
CLOPIDOGREL 69 68 53 44
FLUOXETINE HCL 64 36 56 41
CYCLOBENZAPRINE HCL 63 48 R 57 75
BUSPIRONE HCL 63 40 57 264
CARVEDILOL 62 56 59 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 61 32 60 28
CARISOPRODOL 61 22 R 60 104
ADVAIR DISKUS 60 26 62 47
NAMENDA 59 59 63 39
LANTUS SOLOSTAR 58 29 64 85
ACETAMINOPHEN-CODEINE 57 48 S3 65 79
DILTIAZEM 24HR CD 56 44 66 89
FINASTERIDE 56 49 66 55
PREDNISONE 56 39 66 35
MORPHINE SULFATE ER 56 17 S2 66 70
SERTRALINE HCL 56 48 66 22
FELODIPINE ER 52 48 71 61
BUPROPION HCL SR 51 16 72 121
AMITRIPTYLINE HCL 51 22 R 72 66
PROPRANOLOL HCL 51 50 72 127
ATORVASTATIN CALCIUM 51 43 72 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.